_256_384.jpg)
News | March 01, 2024
Suven announces merger of Cohance Lifesciences
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
VeerHealth Care will be raising Rs. 8 crores through bank borrowings
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
The 200 bedded hospital owned & operated by Alexis
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Studies will Investigate Antidepressant Properties of Ketamir to Position for Initial IND Application in 2024
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
Subscribe To Our Newsletter & Stay Updated
